Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,257.15
(
0.67%
)
US TECH 100
27,012.00
(
1.13%
)
Dow Jones
49,687.97
(
0.07%
)
Brent Oil
106.71
(
-3.30%
)
Bitcoin
78,314.08
(
2.60%
)
News Focus
News Focus
Post# of 257479
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: pcrutch post# 177361

Monday, 04/28/2014 11:33:06 PM

Monday, April 28, 2014 11:33:06 PM

Post# of 257479
Should have no impact at all. PKC412 combo trial is for 1st line AML while Quizartinib single agent trial is for relapsed or refractory AML. I don't think Quizartinib trial excluding previous FLT3 treated patients completely.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today